Publications by authors named "David Bloomfield"

Claim this Profile
A
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Galina Velikova, James P Morden, Joanne S Haviland, Charlotte Emery, Peter Barrett-Lee, David Bloomfield

Lancet Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, David J Bloomfield

Health Technol Assess· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' views and experiences on the supported self-management/patient-initiated follow up pathway for breast cancer.
Valerie Jenkins, Rachel Starkings, May Teoh, Shirley May, David Bloomfield

Support Care Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
Johnathan K Joffe, Fay H Cafferty, Laura Murphy, Gordon J S Rustin, Syed A Sohaib, David Bloomfield

J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016).
John N Staffurth, Joanne S Haviland, Anna Wilkins, Isabel Syndikus, Vincent Khoo, David Bloomfield

Eur Urol Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
Adrian Murray Brunt, Joanne S Haviland, Mark Sydenham, Rajiv K Agrawal, Hafiz Algurafi, David Bloomfield

J Clin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, Abdulla Alhasso, David J Bloomfield

Lancet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing.
Lesley Fallowfield, Lucy Matthews, Shirley May, Valerie Jenkins, David Bloomfield

Psychooncology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy and Safety of Conventional and Hypofractionated High-Dose Radiation Therapy for Prostate Cancer in an Elderly Population: A Subgroup Analysis of the CHHiP Trial.
James M Wilson, David P Dearnaley, Isabel Syndikus, Vincent Khoo, Alison Birtle, David Bloomfield

Int J Radiat Oncol Biol Phys· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
David Cameron, James P Morden, Peter Canney, Galina Velikova, Robert Coleman, David Bloomfield

Lancet Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
David Dearnaley, Isabel Syndikus, Helen Mossop, Vincent Khoo, Alison Birtle, David Bloomfield

Lancet Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Anna Wilkins, Helen Mossop, Isabel Syndikus, Vincent Khoo, David Bloomfield

Lancet Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer.
Peter Hoskin, Santhanam Sundar, Krystyna Reczko, Sharon Forsyth, Natasha Mithal, David Bloomfield

J Natl Cancer Inst· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
L Rhoda Molife, Aurelius Omlin, Rob J Jones, Vasilios Karavasilis, David Bloomfield

Future Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pelvic radiculopathies, lumbosacral plexopathies, and neuropathies in oncologic disease: a multidisciplinary approach to a diagnostic challenge.
Nick Brejt, Jonathan Berry, Angus Nisbet, David Bloomfield, Guy Burkill

Cancer Imaging· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.
David Dearnaley, Isabel Syndikus, Georges Sumo, Margaret Bidmead, David Bloomfield

Lancet Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

Radiother Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narrowing the gap: the effects of an expressive writing intervention on perceptions of actual and ideal emotional support in women who have completed treatment for early stage breast cancer.
Grace Gellaitry, Keri Peters, David Bloomfield, Rob Horne

Psychooncology· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
Paul Ellis, Peter Barrett-Lee, Lindsay Johnson, David Cameron, Andrew Wardley, David Bloomfield

Lancet· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating IIA/B seminoma with combination carboplatin and radiotherapy.
Duncan C Gilbert, Nicholas J Vanas, Sharon Beesley, David Bloomfield, Julian Money-Kyrle

J Clin Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenge of germ cell tumour therapy in dialysis and transplantation.
Caroline Dean, David Bloomfield, Stephen Holt

Nephrol Dial Transplant· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
Valerie A Jenkins, David J Bloomfield, Valerie M Shilling, Trudi L Edginton

BJU Int· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis